About Fisher & Paykel Healthcare Corporation Limited (FPH)
Fisher & Paykel Healthcare Corporation Limited is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Auckland, New Zealand. FPH has been publicly traded since 2001, giving it 25+ years of trading history.
Fisher & Paykel Healthcare Corporation Limited (FPH) has been publicly traded since 2001, making it a 25-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in Auckland, New Zealand and employs approximately 7,384 people. With a market capitalization of A$19 billion, FPH is a large established company.
FPH trades on the Australian Securities Exchange and is classified as a large-cap-cap stock with a market capitalization of approximately A$19 billion. The company employs approximately 7,384 people worldwide.
Key Statistics
- Current Price
- A$31.95
- Market Cap
- A$18.76B
- 52-Week High
- A$35.31
- 52-Week Low
- A$29.08
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
FPH Investment Performance
FPH has declined 2.1% year-to-date in 2026. Over the past 5 years, a A$1,000 investment in FPH would have grown to A$1,167, representing a 16.7% total return. Since its IPO in 2001, a A$1,000 investment would now be worth A$19,593.
A$1,000 Invested in Fisher & Paykel Healthcare Corporation Limited (FPH)
How much would A$1,000 invested in FPH be worth today?
What would A$1,000 invested in FPH 1 year ago be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) in 2025 would be worth A$1,068 as of March 2026, representing a +6.8% total return.
What would A$1,000 invested in FPH 3 years ago be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) in 2023 would be worth A$1,337 as of March 2026, representing a +33.7% total return.
What would A$1,000 invested in FPH 5 years ago be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) in 2021 would be worth A$1,167 as of March 2026, representing a +16.7% total return.
What would A$1,000 invested in FPH 10 years ago be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) in 2016 would be worth A$4,172 as of March 2026, representing a +317.1% total return.
What would A$1,000 invested in FPH at IPO be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) at IPO would be worth A$19,593 as of March 2026, representing a +1859.3% total return.
Monthly Returns Heatmap
Over the past 24+ years (292 months), Fisher & Paykel Healthcare Corporation Limited (FPH) has averaged a monthly return of +1.31% with a median return of +1.26%. The stock had 162 positive months (55%) and 124 negative months (42%). The best month in FPH's history was November 2022 with a +22.8% return, while the worst was February 2002 at -28.6%. Historically, November tends to be the strongest month (averaging +3.9%), and January the weakest (-1.6%).
FPH's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 2013 with a cumulative return of +63.3%, and the worst was 2002 at -32.5%.
Annual Returns
Over 25 years of trading history, Fisher & Paykel Healthcare Corporation Limited (FPH) has delivered an average annual return of +17.42% with a median return of +4.17%. The compound annual growth rate (CAGR) is +12.87%. The stock posted gains in 15 years (60%) and losses in 10 years (40%).
FPH's best year was 2013 with a +81.62% gain, while the worst was 2002 at -34.15%. The longest streak of consecutive positive years was 6, and the longest losing streak was 2 years. FPH achieved double-digit gains (10%+) in 12 years. It suffered double-digit losses in 5 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -2.14% | A$32.65 | A$31.95 |
| 2025 | -5.50% | A$34.55 | A$32.65 |
| 2024 | +62.13% | A$21.31 | A$34.55 |
| 2023 | +4.17% | A$20.46 | A$21.31 |
| 2022 | -28.96% | A$28.80 | A$20.46 |
| 2021 | -0.11% | A$28.83 | A$28.80 |
| 2020 | +48.02% | A$19.48 | A$28.83 |
| 2019 | +73.20% | A$11.24 | A$19.48 |
| 2018 | -2.19% | A$11.50 | A$11.24 |
| 2017 | +59.45% | A$7.21 | A$11.50 |
| 2016 | +0.08% | A$7.20 | A$7.21 |
| 2015 | +43.97% | A$5.00 | A$7.20 |
| 2014 | +69.97% | A$2.94 | A$5.00 |
| 2013 | +81.62% | A$1.62 | A$2.94 |
| 2012 | +10.67% | A$1.46 | A$1.62 |
| 2011 | -19.30% | A$1.81 | A$1.46 |
| 2010 | -14.81% | A$2.13 | A$1.81 |
| 2009 | +3.92% | A$2.05 | A$2.13 |
| 2008 | -8.17% | A$2.23 | A$2.05 |
| 2007 | -15.17% | A$2.63 | A$2.23 |
| 2006 | +13.97% | A$2.31 | A$2.63 |
| 2005 | +20.45% | A$1.92 | A$2.31 |
| 2004 | +38.11% | A$1.39 | A$1.92 |
| 2003 | +36.28% | A$1.02 | A$1.39 |
| 2002 | -34.15% | A$1.55 | A$1.02 |
FPH Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Fisher & Paykel Healthcare Corporation Limited as an investment
Valuation
FPH currently trades at a trailing P/E ratio of 52.4, which is considered high relative to the broader market. The forward P/E of 42.4 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 11.4. The price-to-sales ratio is 8.7.
Dividends
Fisher & Paykel Healthcare Corporation Limited pays a dividend to shareholders with a current yield of 1.21%. This translates to A$0.39 per share annually. The payout ratio of 59% indicates sustainable dividend coverage.
Risk & Volatility
FPH has a beta of 0.93, indicating it is similarly volatile to the overall market. The stock's 52-week range is A$29.08 to A$35.31, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 7 analyst opinions, FPH has a consensus "buy" rating. The average price target of A$35.19 suggests 10.1% upside from current levels.
Frequently Asked Questions: FPH
What sector is FPH in? ▼
FPH operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has FPH performed historically? ▼
Over 25 years of trading history, FPH has posted gains in 15 years (60% of the time). The best year was 2013 with a +81.6% return. Past performance does not guarantee future results.
How can I invest in FPH? ▼
You can invest in FPH through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold FPH.
Does FPH pay dividends? ▼
Fisher & Paykel Healthcare Corporation Limited pays a dividend to shareholders with a current yield of 1.21%. This translates to A$0.39 per share annually. The payout ratio of 59% indicates sustainable dividend coverage.
What does Fisher & Paykel Healthcare Corporation Limited do? ▼
Fisher & Paykel Healthcare Corporation Limited is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Auckland, New Zealand.
What sector is FPH in? ▼
FPH operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
When did FPH go public? ▼
Fisher & Paykel Healthcare Corporation Limited went public in 2001, making it a 25-year-old public company as of 2026.
How much would A$1,000 invested in FPH 5 years ago be worth today? ▼
A A$1,000 investment in FPH five years ago would be worth approximately A$1,167 today, representing a 16.7% return.
How much would A$1,000 invested in FPH 10 years ago be worth today? ▼
A A$1,000 investment in FPH ten years ago would be worth approximately A$4,172 today, representing a 317.1% total return over the decade.
What is FPH's 3-year return? ▼
Over the past 3 years, FPH has returned 33.7%. A A$1,000 investment would have grown to A$1,337.
How much would A$1,000 invested in FPH at IPO be worth today? ▼
If you invested A$1,000 in FPH at its IPO in 2001, it would be worth approximately A$19,593 today, a 1,859.3% return over 25 years.
Does FPH pay dividends? ▼
Yes, Fisher & Paykel Healthcare Corporation Limited pays a dividend with a current yield of 1.21%, which is A$0.39 per share annually.
What is FPH's market cap? ▼
Fisher & Paykel Healthcare Corporation Limited has a market capitalization of A$19 billion, classifying it as a large-cap company.
What is FPH's P/E ratio? ▼
FPH has a trailing P/E ratio of 52.4 and a forward P/E of 42.4, which measures how much investors are paying per dollar of earnings.
Is FPH a buy, hold, or sell? ▼
Based on 7 opinions, FPH has a consensus "buy" rating. The average price target is A$35.19.
Last updated: 3/15/2026